Birdshot Chorioretinopathy treated with dexamethasone intravitreal implant and a biologic response modifier: a successful management
Journal: Revista de Medicina da UFC (Vol.57, No. 3)Publication Date: 2017-12-04
Authors : Ricardo Evangelista Marrocos de Aragao Ieda Maria Alexandre Barreira Cristina Muccioli Francisco Holanda Oliveira Neto Barbara Lorena Alves Arrais Francisco George Magalhães de Oliveira Gustavo Jose Arruda Mendes Carneiro;
Page : 54-57
Keywords : uveitis; birdshot chorioretinopathy; HLA-A29; retinal vasculitis; anti-inflammatory agents;
Abstract
Birdshot chorioretinopathy is an organ-specific, potentially blinding chronic of bilateral inflammation of the posterior eye segment. It is seen mainly in persons who have the HLA-A29 haplotype. The diagnosis remains clinical and is based in his hallmark, which is the presence of multiples white dots throughout the fundus, resembling a shotgun pattern. The immune mechanisms involved in its pathogenesis remains unclear and the long-term outcome is guarded. However, the use of immunosuppressive agents and newer therapies demonstrated control of the inflammation and is a hope mainly in refractory cases. We report a case of Birdshot chorioretinopathy treated successfully with steroids and immunosuppressive agents.
Other Latest Articles
- Associação de transfusão de concentrado de hemácias (CH) e enterocolite necrosante (ECN): relato de caso
- Obesidade infantil: revisão de literatura
- Lesões císticas do pâncreas: uma revisão da literatura
- Tratamento endovascular de estenose de artéria renal em rim transplantado
- Cirurgia de alta frequência no colo uterino: análise dos fatores de recidiva
Last modified: 2017-12-05 22:55:12